Work With Your Doctor to Get Xospata (gilteritinib) Approved by Blue Cross Blue Shield in Washington
Quick Answer: Your Path to Xospata Approval
To get Xospata (gilteritinib) covered by Blue Cross Blue Shield in Washington, you'll need: confirmed FLT3 mutation testing, documentation of relapsed/refractory AML status, and evidence of prior therapy failures. Start by scheduling a comprehensive visit with your hematologist to gather